Extracorporeal Life Support: The Evolution of ECMO Devices Market
The global market for Extracorporeal Membrane Oxygenation (ECMO) devices is projected to experience a compound annual growth rate (CAGR) of 4.1% from 2024 to 2030. The increasing demand for ECMO devices is largely driven by the rising prevalence of chronic respiratory and cardiac conditions, technological advancements that improve patient outcomes, and a growing adoption of ECMO machines. Furthermore, the introduction of innovative technologies by leading market players, along with the rising incidence of lung and heart diseases and a growing number of product launches and regulatory approvals, is propelling market growth.
Key Developments in the ECMO Devices Market:
August 2022: AirECMO, Inc., a division of Keystone Perfusion Services, partnered with REVA, a leading air ambulance provider, to enhance ECMO transportation capabilities globally.
July 2022: Inspira™ Technologies launched the Liby System, an advanced ECMO-based life support system aimed at patients with severe heart and lung failure.
April 2020: The U.S. Food and Drug Administration (FDA) released guidelines to improve the availability of ECMO devices to address the COVID-19 pandemic.
April 2020: Abiomed acquired Breethe, a company developing innovative ECMO systems, to expand its product offerings and better serve patients with respiratory failure or cardiogenic shock due to conditions like ARDS, H1N1, SARS, and COVID-19.
Market Dynamics Driving ECMO Adoption
A key factor driving the growth of the ECMO devices market is the rising incidence of cardiovascular and respiratory diseases. ECMO systems provide long-term respiratory or cardiopulmonary support by facilitating extracorporeal circulation and gas exchange for extended periods. Ischemic heart disease (IHD), also known as coronary artery disease (CAD), remains a leading cause of death globally. A 2020 study revealed that approximately 126 million people, or 1.72% of the global population, are affected by IHD each year. Cardiovascular surgeries often require artificial circulatory support, further boosting the demand for ECMO devices.
According to the British Heart Foundation (2023), around 620 million people worldwide live with heart and circulatory diseases, and cardiovascular diseases were responsible for approximately 17.9 million deaths in 2021, representing 31% of all global deaths. This figure is expected to rise to 23.6 million by 2030.
ECMO Devices Market Segmentation
The ECMO devices market is segmented by machine modality, patient type, application, and geography:
By Machine Modality: Veno-Arterial, Veno-Venous, and Arterio-Venous
By Patient Type: Pediatric and Adult
By Application: Respiratory, Cardiac, and Others
By Geography: North America, Europe, Asia-Pacific, and Rest of the World
The respiratory application segment is expected to capture a significant share of the market due to the high prevalence of respiratory diseases. Asthma, one of the major non-communicable diseases, affects millions globally. The World Health Organization (WHO) reported that in 2019, approximately 262 million people had asthma, resulting in 250,000 deaths annually. ECMO's role in treating severe COVID-19 cases has also grown, as it has been shown to improve survival rates for critically ill patients when conventional ventilation methods failed. According to the Extracorporeal Life Support Organization (ELSO), about 55% of COVID-19 patients placed on ECMO survived.
North America Leads the ECMO Devices Market
North America is expected to maintain its dominant position in the ECMO devices market due to a combination of factors, including the high prevalence of cardiovascular and pulmonary diseases, an aging population, and ongoing product innovations. The COVID-19 pandemic further accelerated demand for compact cardiopulmonary bypass systems. In October 2020, Abiomed received FDA 510(k) clearance for its Breethe OXY-1 system, which significantly contributed to the growth of the ECMO market in the United States. Additionally, data from the Centers for Disease Control and Prevention (CDC) shows the growing demand for ECMO systems, with more than 795,000 people suffering strokes annually in the U.S. and around 200,000 coronary artery bypass graft surgeries performed each year.
Key Players in the ECMO Devices Market
Several companies are actively influencing the ECMO devices market, including:
Getinge Group
Medtronic
LivaNova PLC
XENIOS AG
Terumo Corporation
MicroPort Scientific Corporation
NIPRO Corporation
OriGen Biomedical, Inc.
EUROSETS S.r.l.
ALung Technologies, Inc.
Medos Medizintechnik AG
Abiomed
Novalung
Sorin
Thoratec Corporation
MAQUET Holding B.V. & Co. KG
Tianjin Medical
SHANDONG WEGO NEW LIFE MEDICAL DEVICES CO., LTD.
In conclusion, the ECMO devices market is poised for steady growth driven by the increasing burden of cardiovascular and respiratory diseases, technological advancements, and the rising global adoption of ECMO systems. North America is expected to continue leading the market, benefiting from a robust healthcare infrastructure and growing product approvals. As new market entrants emerge and existing players innovate, the ECMO devices industry is set to expand significantly in the coming years.
Related Reports by DelveInsight:
Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Info:
Kritika Rehani
krehani@delveinsight.com
+14699457679
